Intact Chorionic Villus Sampling (ICVS): Definition, Procedure & Risks
Intact Chorionic Villus Sampling (ICVS) is a first-trimester prenatal diagnostic technique that obtains a contiguous villous tissue sample for genetic analysis. It's a variant of standard CVS designed to reduce maternal cell contamination and improve diagnostic yield for certain conditions.
Indications
- Advanced maternal age (≥35)
- Positive aneuploidy screen (NIPT, combined screen)
- Prior child with chromosomal abnormality
- Parental balanced translocation / inversion
- Fetal structural anomaly on ultrasound
- Family history of genetic disorder amenable to CVS testing
Procedure (10–13+6 weeks gestation)
- Ultrasound guidance: Continuous real-time. Confirms viability, placental location, fetal position.
- Route selection:
- Transcervical: Catheter through cervix to placental bed. Preferred for anterior/fundal placenta.
- Transabdominal: Needle through abdominal wall. Preferred for posterior placenta, retroverted uterus, cervical stenosis, infection risk.
- Intact sampling: Specialized catheter/needle obtains a contiguous villous fragment (vs. aspirated fragments in standard CVS), preserving tissue architecture.
- Sample processing: Villi separated from decidua (maternal tissue) under microscope — critical for reducing maternal cell contamination (MCC).
- Genetic analysis: Direct prep (FISH/PCR for rapid aneuploidy: 13, 18, 21, X, Y — 24–48 hrs), culture for karyotype (10–14 days), CMA (chromosomal microarray — detects microdeletions/duplications), targeted gene sequencing.
Advantages of Intact Sampling
- Lower MCC rate (<1% vs. 1–2% standard CVS) — reduces false mosaicism / need for amniocentesis confirmation.
- Better tissue for molecular studies (RNA, protein, epigenetics).
- May improve detection of confined placental mosaicism (CPM) interpretation.
Risks
- Procedure-related loss: ~0.2–0.5% (1:200–1:500) — slightly higher than amniocentesis (0.1–0.3%), operator-dependent.
- Transient cramping, spotting (common).
- Rh sensitization (RhIg given if Rh-negative).
- Infection (rare).
- Limb reduction defects — theoretical if <10 wks; not observed at 10+ wks.
CVS vs. Amniocentesis
| CVS (ICVS) | Amniocentesis | |
|---|---|---|
| Gestational age | 10–13+6 wks | 15–20+ wks |
| Sample | Placental (trophoblast) | Amniotic fluid (fetal cells) |
| MCC risk | Low (lower with intact) | Negligible |
| CPM detection | Yes | No (fetal only) |
| Neural tube defects | No (AF-AFP not available) | Yes (AF-AFP) |
| Loss rate | ~0.2–0.5% | ~0.1–0.3% |
Decision-Making
Choose CVS for earlier answers. Choose amnio for NTD screening, later gestation, or if CVS results ambiguous (CPM). Genetic counselor essential for pre/post-test counseling.
Bones, Joints & Muscles - Related Articles
- External Urethral Sphincter: Anatomy, Voluntary Control, and Clinical Significance
- Bone Marrow Transplant Risks & Potential Complications | NLM
- Carpal Tunnel Syndrome Relief: Exploring the Potential of Healing Crystals
- Understanding Bone Mineral Density: Factors & Prevention
- Ankle Pain Relief: Causes, Treatments & Recovery
- Restore Knee Mobility: Effective Exercises for Improved Range of Motion
- Swollen Legs & Ankles: Causes, Symptoms & Solutions
